¹⁸F-FDG PET/CT Parameters for Predicting Prognosis in Esophageal Cancer Patients Treated With Concurrent Chemoradiotherapy.

ABSTRACT:

Background and aims

This study evaluated the prognostic value of ¹⁸F-fluorodeoxyglucose positron emission tomography with integrated computed tomography (¹⁸F-FDG PET/CT) performed before and after concurrent chemoradiotherapy (CCRT) in esophageal cancer.

Methods

We analyzed the prognosis of 50 non-metastatic squamous cell esophageal cancer (T1-4N0-2) patients who underwent CCRT with curative intent at Inje University Busan Paik Hospital and Haeundae Paik Hospital from 2009 to 2019. Median total radiation dose was 54 Gy (range 34-66 Gy). Our aim was to investigate the relationship between PET/CT values and prognosis. The primary end point was progression-free survival (PFS).

Results

The median follow-up period was 9.9 months (range 1.7-85.7). Medi

SUBMITTER: Lee S 

PROVIDER: S-EPMC8264725 | biostudies-literature | 2021 Jan-Dec

REPOSITORIES: biostudies-literature